NXTC – Nextcure Inc
Float Short %
0.68
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.76
EPS Last/This Y
9.58
EPS This/Next Y
3.56
Price
12.34
Target Price
17.67
Analyst Recom
1
Performance Q
150.71
Relative Volume
0.5
Beta
1.54
Ticker: NXTC
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | NXTC | 8.35 | N/A | N/A | 0 |
| 2025-11-11 | NXTC | 8.19 | N/A | N/A | 0 |
| 2025-11-12 | NXTC | 9.5 | N/A | N/A | 0 |
| 2025-11-13 | NXTC | 9.63 | N/A | N/A | 0 |
| 2025-11-14 | NXTC | 9.46 | N/A | N/A | 0 |
| 2025-11-17 | NXTC | 9.94 | N/A | N/A | 0 |
| 2025-11-18 | NXTC | 9.7375 | N/A | N/A | 0 |
| 2025-11-19 | NXTC | 9.63 | N/A | N/A | 0 |
| 2025-11-20 | NXTC | 9.28 | N/A | N/A | 0 |
| 2025-11-21 | NXTC | 10.35 | N/A | N/A | 0 |
| 2025-11-24 | NXTC | 14.3 | N/A | N/A | 0 |
| 2025-11-25 | NXTC | 13.92 | N/A | N/A | 0 |
| 2025-11-26 | NXTC | 13.62 | N/A | N/A | 0 |
| 2025-12-01 | NXTC | 13.3 | 0.00 | 0.00 | 3 |
| 2025-12-02 | NXTC | 12.55 | 0.00 | 0.00 | 3 |
| 2025-12-03 | NXTC | 11.92 | 0.00 | 0.00 | 3 |
| 2025-12-04 | NXTC | 12.75 | 0.00 | 0.00 | 3 |
| 2025-12-05 | NXTC | 12.47 | 0.00 | 0.00 | 3 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | NXTC | 8.50 | 26.2 | - | -15.59 |
| 2025-11-11 | NXTC | 8.52 | 26.2 | - | -15.59 |
| 2025-11-12 | NXTC | 9.36 | 26.2 | - | -15.59 |
| 2025-11-13 | NXTC | 9.69 | 26.2 | -1960.8 | -15.59 |
| 2025-11-14 | NXTC | 9.75 | 26.2 | -18.3 | -22.84 |
| 2025-11-17 | NXTC | 10.15 | 28.0 | -190.6 | -19.11 |
| 2025-11-18 | NXTC | 9.76 | 28.0 | 14.3 | -19.11 |
| 2025-11-19 | NXTC | 9.36 | 28.0 | 30.7 | -19.11 |
| 2025-11-20 | NXTC | 9.31 | 28.0 | 45.3 | -19.11 |
| 2025-11-21 | NXTC | 10.22 | 37.5 | - | -14.71 |
| 2025-11-24 | NXTC | 14.31 | 37.5 | -176.4 | -14.71 |
| 2025-11-25 | NXTC | 13.95 | 37.5 | 15.0 | -14.71 |
| 2025-11-26 | NXTC | 13.73 | 37.5 | 13.6 | -14.71 |
| 2025-12-01 | NXTC | 13.41 | 45.9 | 17.7 | -14.30 |
| 2025-12-02 | NXTC | 12.55 | 45.9 | 19.3 | -14.30 |
| 2025-12-03 | NXTC | 12.03 | 45.9 | 17.9 | -14.30 |
| 2025-12-04 | NXTC | 12.93 | 45.9 | 4.5 | -14.30 |
| 2025-12-05 | NXTC | 12.34 | 45.9 | 15.0 | -14.30 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | NXTC | 0.00 | -14.15 | 0.75 |
| 2025-11-11 | NXTC | 0.00 | -14.15 | 0.75 |
| 2025-11-12 | NXTC | 0.00 | -14.15 | 2.09 |
| 2025-11-13 | NXTC | 0.00 | -14.15 | 2.09 |
| 2025-11-14 | NXTC | 0.00 | -14.15 | 2.09 |
| 2025-11-17 | NXTC | 0.00 | -8.64 | 2.09 |
| 2025-11-18 | NXTC | 0.00 | -8.64 | 2.09 |
| 2025-11-19 | NXTC | 0.00 | -8.64 | 2.09 |
| 2025-11-20 | NXTC | 0.00 | -8.64 | 2.09 |
| 2025-11-21 | NXTC | 0.00 | -8.64 | 2.09 |
| 2025-11-24 | NXTC | 0.00 | -0.76 | 2.09 |
| 2025-11-25 | NXTC | 0.00 | -0.76 | 2.09 |
| 2025-11-26 | NXTC | 0.00 | -0.76 | 1.32 |
| 2025-12-01 | NXTC | 0.00 | -0.25 | 1.32 |
| 2025-12-02 | NXTC | 0.00 | -0.25 | 1.32 |
| 2025-12-03 | NXTC | 0.00 | -0.25 | 1.32 |
| 2025-12-04 | NXTC | 0.00 | -0.25 | 0 |
| 2025-12-05 | NXTC | 0.00 | -0.25 | 0.68 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-3.22
Avg. EPS Est. Current Quarter
-2.66
Avg. EPS Est. Next Quarter
-2.46
Insider Transactions
Institutional Transactions
-0.25
Beta
1.54
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
19
Sentiment Score
72
Actual DrawDown %
92.9
Max Drawdown 5-Year %
-98.1
Target Price
17.67
P/E
Forward P/E
PEG
P/S
P/B
1.4
P/Free Cash Flow
EPS
-24.19
Average EPS Est. Cur. Y
-14.3
EPS Next Y. (Est.)
-10.74
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.5
Return on Equity vs Sector %
-272.2
Return on Equity vs Industry %
-257.3
EPS 1 7Days Diff
4.8
EPS 1 30Days Diff
1.29
EBIT Estimation
15
NextCure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 43
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading